{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:56:58Z","timestamp":1772240218777,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013421","name":"Pink Ribbon Foundation","doi-asserted-by":"crossref","award":["2011.WO23.C129"],"award-info":[{"award-number":["2011.WO23.C129"]}],"id":[{"id":"10.13039\/100013421","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.cct.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T18:46:53Z","timestamp":1499798813000},"page":"96-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial"],"prefix":"10.1016","volume":"61","author":[{"given":"T.","family":"Dahhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.E.","family":"Balkenende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.M.","family":"Beerendonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Stoop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.E.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.B.","family":"Lambalk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Schats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.J.T.","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Louw\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.P.","family":"Cantineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.J.","family":"Smeenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kopeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Linn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Goddijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2017.07.009_bb0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cct.2017.07.009_bb0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1200\/JCO.1996.14.5.1718","article-title":"Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer","volume":"14","author":"Bines","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0960-0760(03)00365-0","article-title":"Hormonal effects of aromatase inhibitors: focus on premenopausal effects and interaction with tamoxifen","volume":"86","author":"Dowsett","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cct.2017.07.009_bb0020","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1634\/theoncologist.11-5-422","article-title":"Fertility preservation in young women undergoing breast cancer therapy","volume":"11","author":"Sonmezer","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.cct.2017.07.009_bb0025","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11864-010-0116-2","article-title":"Maintaining fertility in young women with breast cancer","volume":"10","author":"Hulvat","year":"2009","journal-title":"Curr. Treat. Options in Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GRF.0b013e3181f96e00","article-title":"Fertility preservation in women with breast cancer","volume":"53","author":"Rodriguez-Wallberg","year":"2010","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.cct.2017.07.009_bb0035","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on. fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0040","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2009.06.001","article-title":"GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study","volume":"19","author":"Melo","year":"2009","journal-title":"Reprod. BioMed. Online"},{"key":"10.1016\/j.cct.2017.07.009_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humupd\/dmr008","article-title":"GnRH agonist for triggering of final oocyte maturation: time for a change of practice?","volume":"17","author":"Humaidan","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.cct.2017.07.009_bb0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis","volume":"95","author":"Bodri","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cct.2017.07.009_bb0055","series-title":"Yen & Jaffe's Reproductive Endocrinology","article-title":"Female infertility","author":"Barbieri","year":"2009"},{"key":"10.1016\/j.cct.2017.07.009_bb0060","series-title":"The Structure, Function, and Evaluation of the Female Reproductive Tract","author":"Strauss","year":"2009"},{"key":"10.1016\/j.cct.2017.07.009_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1056\/NEJM200101253440407","article-title":"Estrogen and the risk of breast cancer","volume":"344","author":"Clemons","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cct.2017.07.009_bb0070","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2017.07.009_bb0075","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","article-title":"American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for. women with hormone receptor-positive breast cancer","volume":"28","author":"Burstein","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0080","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant. tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen. receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2017.07.009_bb0085","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1200\/JCO.2013.49.2678","article-title":"Fertility preservation for patients with cancer: American society of clinical oncology clinical practice guideline update","volume":"31","author":"Loren","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0090","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3109\/09513590.2013.819083","article-title":"Is letrozole. needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?","volume":"29","author":"Revelli","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cct.2017.07.009_bb0095","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0100","article-title":"Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction","volume":"11","author":"Dahhan","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cct.2017.07.009_bb0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cct.2017.07.009_bb0110","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1200\/JCO.2007.14.8700","article-title":"Safety of fertility preservation by. ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study","volume":"26","author":"Azim","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2017.07.009_bb0115","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1093\/humrep\/del152","article-title":"Comparison between. a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a. randomized clinical trial","volume":"21","author":"Bodri","year":"2006","journal-title":"Hum. Reprod."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417304627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714417304627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T02:13:31Z","timestamp":1589768011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714417304627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"alternative-id":["S1551714417304627"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2017.07.009","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}